JP2007523123A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007523123A5 JP2007523123A5 JP2006553558A JP2006553558A JP2007523123A5 JP 2007523123 A5 JP2007523123 A5 JP 2007523123A5 JP 2006553558 A JP2006553558 A JP 2006553558A JP 2006553558 A JP2006553558 A JP 2006553558A JP 2007523123 A5 JP2007523123 A5 JP 2007523123A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- cancer
- tumor
- resistance
- pharmaceutical ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 claims 15
- 239000004615 ingredient Substances 0.000 claims 4
- 229940123237 Taxane Drugs 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 230000001404 mediated effect Effects 0.000 claims 3
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 230000036457 multidrug resistance Effects 0.000 claims 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 2
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims 2
- 210000004881 tumor cell Anatomy 0.000 claims 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 2
- 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 claims 1
- 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
- 206010059866 Drug resistance Diseases 0.000 claims 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 1
- 229930012538 Paclitaxel Natural products 0.000 claims 1
- 206010041067 Small cell lung cancer Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 102000004243 Tubulin Human genes 0.000 claims 1
- 108090000704 Tubulin Proteins 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 230000001142 anti-diarrhea Effects 0.000 claims 1
- 230000003474 anti-emetic effect Effects 0.000 claims 1
- 239000002111 antiemetic agent Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 229960003668 docetaxel Drugs 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 201000010536 head and neck cancer Diseases 0.000 claims 1
- 208000014829 head and neck neoplasm Diseases 0.000 claims 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims 1
- 208000037819 metastatic cancer Diseases 0.000 claims 1
- 208000011575 metastatic malignant neoplasm Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000002018 overexpression Effects 0.000 claims 1
- 229960001592 paclitaxel Drugs 0.000 claims 1
- 201000002628 peritoneum cancer Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000008261 resistance mechanism Effects 0.000 claims 1
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 230000004614 tumor growth Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54609704P | 2004-02-18 | 2004-02-18 | |
| PCT/EP2005/001733 WO2005077385A2 (en) | 2004-02-18 | 2005-02-18 | Methods for treating resistant or refractory tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007523123A JP2007523123A (ja) | 2007-08-16 |
| JP2007523123A5 true JP2007523123A5 (https=) | 2008-04-10 |
Family
ID=34860531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006553558A Pending JP2007523123A (ja) | 2004-02-18 | 2005-02-18 | 耐性又は不応性腫瘍の治療方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20080058411A1 (https=) |
| EP (2) | EP1967189A1 (https=) |
| JP (1) | JP2007523123A (https=) |
| CN (1) | CN1933829A (https=) |
| AT (1) | ATE397924T1 (https=) |
| AU (1) | AU2005211937B2 (https=) |
| CA (1) | CA2555811A1 (https=) |
| CY (1) | CY1108780T1 (https=) |
| DE (1) | DE602005007471D1 (https=) |
| DK (1) | DK1720540T3 (https=) |
| ES (1) | ES2308451T3 (https=) |
| HR (1) | HRP20080422T3 (https=) |
| IL (1) | IL177555A0 (https=) |
| PL (1) | PL1720540T3 (https=) |
| PT (1) | PT1720540E (https=) |
| RS (1) | RS50605B (https=) |
| SI (1) | SI1720540T1 (https=) |
| WO (1) | WO2005077385A2 (https=) |
| ZA (1) | ZA200607780B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ2004964A3 (cs) * | 2004-09-14 | 2006-03-15 | Pliva-Lachema A. S. | Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo |
| EP1905437A1 (en) * | 2006-09-24 | 2008-04-02 | GPC Biotech AG | Treatment of pain using satraplatin |
| EP1905439A1 (en) * | 2006-09-24 | 2008-04-02 | GPC Biotech AG | Second line treatment of metastatic hormone refractory prostate cancer using satraplatin |
| FR2906533B1 (fr) | 2006-09-28 | 2013-02-22 | Pf Medicament | Procede de generation d'anticorps actifs contre un antigene de resistance,anticorps obtenus par ledit procede et leurs utilisations |
| JP2010518088A (ja) * | 2007-02-09 | 2010-05-27 | ポニアード ファーマシューティカルズ， インコーポレイテッド | カプセル化されたピコプラチン |
| RU2455991C1 (ru) * | 2011-07-05 | 2012-07-20 | Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии Сибирского отделения РАМН | Средство, препятствующее развитию нарушений в легочной ткани при цитостатическом воздействии |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4329299A (en) | 1979-08-23 | 1982-05-11 | Johnson, Matthey & Co., Limited | Composition of matter containing platinum |
| GB8328218D0 (en) | 1983-10-21 | 1983-11-23 | Johnson Matthey Plc | Oral compositions |
| GB8416048D0 (en) | 1984-06-22 | 1984-07-25 | Johnson Matthey Plc | Anti-tumour compounds of platinum |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4710384A (en) | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
| US5072011A (en) | 1988-02-02 | 1991-12-10 | Johnson Matthey, Inc. | Pt(IV) complexes |
| US5244919A (en) | 1988-02-02 | 1993-09-14 | Johnson Matthey, Inc. | Pt(IV) complexes as anti-tumor agents |
| US4942184A (en) | 1988-03-07 | 1990-07-17 | The United States Of America As Represented By The Department Of Health And Human Services | Water soluble, antineoplastic derivatives of taxol |
| GB8806044D0 (en) | 1988-03-14 | 1988-04-13 | Johnson Matthey Plc | Platinum coordination compounds |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| US5440056A (en) | 1992-04-17 | 1995-08-08 | Abbott Laboratories | 9-deoxotaxane compounds |
| US6025473A (en) * | 1992-10-27 | 2000-02-15 | Queen's University At Kingston | Multidrug resistance proteins |
| AP9300587A0 (en) | 1992-11-12 | 1995-05-05 | Glaxo Inc | Water soluble camptothecin derivatives. |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| US5475322A (en) | 1993-10-12 | 1995-12-12 | Wang Laboratories, Inc. | Clock frequency multiplying and squaring circuit and method |
| US6210917B1 (en) | 1993-12-29 | 2001-04-03 | The Regents Of The University Of California | Method for suppressing multiple drug resistance in cancer cells |
| GB9408218D0 (en) | 1994-04-26 | 1994-06-15 | Johnson Matthey Plc | Improvements in platinum complexes |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| US5547982A (en) | 1995-02-27 | 1996-08-20 | Johnson Matthey, Inc. | Anti-tumor platinum complexes |
| US20040072889A1 (en) * | 1997-04-21 | 2004-04-15 | Pharmacia Corporation | Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
| US6413953B1 (en) | 1999-04-13 | 2002-07-02 | Anormed Inc. | Pt(IV) antitumor agent |
| DK1165576T3 (da) | 1999-04-13 | 2006-03-27 | Anormed Inc | Fremgangsmåde til fremstilling af amin-platin-komplekser |
| US7179588B1 (en) | 1999-05-20 | 2007-02-20 | Board Of Regents Of The University Of Texas System | Assay for the detection of paclitaxel resistant cells in human tumors |
| US6380405B1 (en) | 1999-09-13 | 2002-04-30 | Nobex Corporation | Taxane prodrugs |
| CA2307393A1 (en) * | 2000-05-01 | 2001-11-01 | The University Of British Columbia | Ginsenoside chemotherapy |
| US6894049B1 (en) | 2000-10-04 | 2005-05-17 | Anormed, Inc. | Platinum complexes as antitumor agents |
| US7351542B2 (en) | 2002-05-20 | 2008-04-01 | The Regents Of The University Of California | Methods of modulating tubulin deacetylase activity |
| US6933302B2 (en) | 2002-06-03 | 2005-08-23 | California Pacific Medical Center | Nitrogen-based homo-camptothecin derivatives |
| GB0312407D0 (en) * | 2003-05-29 | 2003-07-02 | Pharma Mar Sau | Treatment |
-
2005
- 2005-02-18 WO PCT/EP2005/001733 patent/WO2005077385A2/en not_active Ceased
- 2005-02-18 EP EP08102968A patent/EP1967189A1/en not_active Withdrawn
- 2005-02-18 AT AT05715410T patent/ATE397924T1/de active
- 2005-02-18 CN CNA2005800093749A patent/CN1933829A/zh active Pending
- 2005-02-18 RS RSP-2008/0408A patent/RS50605B/sr unknown
- 2005-02-18 JP JP2006553558A patent/JP2007523123A/ja active Pending
- 2005-02-18 EP EP05715410A patent/EP1720540B1/en not_active Expired - Lifetime
- 2005-02-18 PL PL05715410T patent/PL1720540T3/pl unknown
- 2005-02-18 SI SI200530388T patent/SI1720540T1/sl unknown
- 2005-02-18 PT PT05715410T patent/PT1720540E/pt unknown
- 2005-02-18 ES ES05715410T patent/ES2308451T3/es not_active Expired - Lifetime
- 2005-02-18 AU AU2005211937A patent/AU2005211937B2/en not_active Ceased
- 2005-02-18 DK DK05715410T patent/DK1720540T3/da active
- 2005-02-18 HR HR20080422T patent/HRP20080422T3/xx unknown
- 2005-02-18 DE DE602005007471T patent/DE602005007471D1/de not_active Expired - Lifetime
- 2005-02-18 CA CA002555811A patent/CA2555811A1/en not_active Abandoned
- 2005-02-18 US US10/589,840 patent/US20080058411A1/en not_active Abandoned
-
2006
- 2006-08-17 IL IL177555A patent/IL177555A0/en unknown
- 2006-09-18 ZA ZA200607780A patent/ZA200607780B/en unknown
-
2008
- 2008-09-10 CY CY20081100970T patent/CY1108780T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2342159C2 (ru) | Комбинированная терапия негематологических злокачественных опухолей с использованием анти-igf-1r-антитела | |
| JP2010514787A5 (https=) | ||
| Markman et al. | Paclitaxel in cancer therapy | |
| RU2400232C2 (ru) | Комбинации терапевтических агентов для лечения рака | |
| Galsky et al. | Cabazitaxel | |
| ES2576289T3 (es) | Nanopartículas de paclitaxel y albúmina en combinación con bevacizumab contra el cáncer | |
| Seligmann et al. | Tubulin: an example of targeted chemotherapy | |
| JP2006503919A5 (https=) | ||
| RU2016112608A (ru) | Лечение рака комбинацией плинабулина и таксана | |
| JP2016536352A5 (https=) | ||
| JP2011079858A5 (https=) | ||
| RU2016132759A (ru) | Дуокармициновые adc, демонстрирующие улучшенную противоопухолевую активность in vivo | |
| JP2017171685A5 (https=) | ||
| JP2019521180A5 (https=) | ||
| JP2014512356A5 (https=) | ||
| JP2005511597A5 (https=) | ||
| RU2010140890A (ru) | Улучшенные способы противоопухолевого лечения | |
| JP2003533485A5 (https=) | ||
| RU2010151602A (ru) | Комбинированная терапия с помощью рм00104 и другого противоопухолевого средства | |
| JP2019524713A5 (https=) | ||
| Nabell et al. | Docetaxel with concurrent radiotherapy in head and neck cancer | |
| JP2009536956A (ja) | 抗癌治療法 | |
| JP2015507020A5 (https=) | ||
| JP2011517455A5 (https=) | ||
| JP2007523123A5 (https=) |